Response Genetics, Inc. to Release Third Quarter 2014 Financial Results and Host Conference Call on November 13, 2014
LOS ANGELES, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, will announce its third quarter 2014 financial results and give an operational update in a press release to be issued before the market opens on Thursday, November 13, 2014. The company will host a conference call that same day at 8:30 a.m. EST to discuss its financial results.
Why can't it be good for both? Good return for SWKH as long as RGDX repays loan. RGDX can use loan money to straighten itself out (at a pretty penny). Hopefully SWKH did their due diligence. Fact is they probably wouldn't want to fleece (severely overcharge) their client nor would they want to invest in a bad situation. SWKH will ONLY benefit from win-win situation.
I'm genuinely curious why price would be held back. Nobody's buying RGDX at these rock bottom prices. It doesn't seem like it's being held back for purposes of acquiring stock. Or am I missing something? I'm a newbie.....